Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Harvard Startups
June 15th, 2026
Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences built a device called a pico-calorimeter that directly measures heat signals from small groups of living cells. The device could lead to advances in bacterial growth monitoring or antibiotic resistance testing.
May 11th, 2026
Harvard University has expanded a research alliance agreement with Northpond Labs to fund translational research, accelerate commercialization, and advance breakthrough healthcare innovations across Harvard labs at the Wyss Institute, Harvard Medical School, John A. Paulson School of Engineering and Applied Sciences, and Faculty of Arts and Sciences.
May 1st, 2026
Within Harvard's Quantum Initiative in Science and Engineering, an entrepreneurial ecosystem has emerged, fostering industry collaborations and the launch of three startups to advance quantum computing and networking.
April 9th, 2026
Organ Chips developed at the Wyss Institute and commercialized by Emulate were aboard NASA’s Artemis II mission. Wyss and Emulate scientists will study the Bone Marrow Chips to understand how microgravity and radiation affect the human body.
March 2nd, 2026
Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.
